110 related articles for article (PubMed ID: 17314529)
41. HIV infection in a patient with alpha-1 antitrypsin deficiency: a detrimental combination?
Potthoff AV; Münch J; Kirchhoff F; Brockmeyer NH
AIDS; 2007 Oct; 21(15):2115-6. PubMed ID: 17885308
[No Abstract] [Full Text] [Related]
42. Current status of HIV infection: a review for non-HIV-treating physicians.
Knoll B; Lassmann B; Temesgen Z
Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
[TBL] [Abstract][Full Text] [Related]
43. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
[TBL] [Abstract][Full Text] [Related]
44. [Case report: heavy infection of Strongyloides stercoralis complicated with meningioma and cholelithiasis].
Su SL; Chen GF; Zhang RQ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):9. PubMed ID: 16042198
[No Abstract] [Full Text] [Related]
45. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
[TBL] [Abstract][Full Text] [Related]
46. Specific IgA and IgG antibodies in paired serum and breast milk samples in human strongyloidiasis.
Mota-Ferreira DM; Gonçalves-Pires Mdo R; Júnior AF; Sopelete MC; Abdallah VO; Costa-Cruz JM
Acta Trop; 2009 Feb; 109(2):103-7. PubMed ID: 19007741
[TBL] [Abstract][Full Text] [Related]
47. Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytoma.
Shorman M; Al-Tawfiq JA
Int J Infect Dis; 2009 Sep; 13(5):e288-91. PubMed ID: 19231269
[TBL] [Abstract][Full Text] [Related]
48. An inverse relationship between autoimmune liver diseases and Strongyloides stercoralis infection.
Aoyama H; Hirata T; Sakugawa H; Watanabe T; Miyagi S; Maeshiro T; Chinen T; Kawane M; Zaha O; Nakayoshi T; Kinjo F; Fujita J
Am J Trop Med Hyg; 2007 May; 76(5):972-6. PubMed ID: 17488925
[TBL] [Abstract][Full Text] [Related]
49. [Strongyloides stercoralis hyperinfection syndrome with acute meningoencephalitis associated to HTLV-1 and HTLV-2 virus co-infection].
N'dri K; Kouame KE; Sahari R; Hommel D; Hulin A
Med Mal Infect; 2008 Mar; 38(3):162-4. PubMed ID: 18191522
[No Abstract] [Full Text] [Related]
50. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
51. Increased detection rate of Strongyloides stercoralis by repeated stool examinations using the agar plate culture method.
Hirata T; Nakamura H; Kinjo N; Hokama A; Kinjo F; Yamane N; Fujita J
Am J Trop Med Hyg; 2007 Oct; 77(4):683-4. PubMed ID: 17978071
[TBL] [Abstract][Full Text] [Related]
52. Elevated plasma levels of high mobility group box protein 1 in patients with HIV-1 infection.
Nowak P; Barqasho B; Sönnerborg A
AIDS; 2007 Apr; 21(7):869-71. PubMed ID: 17415043
[TBL] [Abstract][Full Text] [Related]
53. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
54. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
55. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
56. Modeling CD4+ cell count increase over a six-year period in HIV-1-infected patients on highly active antiretroviral therapy in Senegal.
De Beaudrap P; Etard JF; Diouf A; Ndiaye I; Guèye NF; Guèye PM; Sow PS; Mboup S; Ndoye I; Ecochard R; Eric D;
Am J Trop Med Hyg; 2009 Jun; 80(6):1047-53. PubMed ID: 19478274
[TBL] [Abstract][Full Text] [Related]
57. Quality of life and immune activation in patients with HIV-infection.
Schroecksnadel K; Sarcletti M; Winkler C; Mumelter B; Weiss G; Fuchs D; Kemmler G; Zangerle R
Brain Behav Immun; 2008 Aug; 22(6):881-9. PubMed ID: 18261883
[TBL] [Abstract][Full Text] [Related]
58. Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralis.
van Kuijk AW; Kerstens PJ; Perenboom RM; Dijkmans BA; Voskuyl AE
Rheumatology (Oxford); 2003 Nov; 42(11):1419-20. PubMed ID: 14578438
[No Abstract] [Full Text] [Related]
59. Strongyloides stercoralis in a bronchoalveolar lavage processed as ThinPrep.
Avant CC; Hitchcock T; Colello CJ; Hoda RS
Diagn Cytopathol; 2007 Aug; 35(8):503-4. PubMed ID: 17636493
[No Abstract] [Full Text] [Related]
60. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H
Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
